intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Sotelix Endoscopy, Inc. Announces Oversubscribed $1.7 Million Seed Round

Sotelix Endoscopy, Inc. Announces Oversubscribed $1.7 Million Seed Round

January 8, 2025 Craig Etkin

Funding will advance development of next-generation therapeutic endoscopy devices

December 19, 2024 08:55 AM Eastern Standard Time

BALTIMORE–(BUSINESS WIRE)–Sotelix Endoscopy, a medical device startup developing next-generation therapeutic endoscopy devices, today announced the closing of a $1.7 million seed round financing. The investment will fund the company’s research and development efforts, including in vivo testing of its innovative device.

“Therapeutic endoscopy holds the potential to treat numerous gastrointestinal conditions in a minimally invasive manner, but achieving this requires the right tools”Post this

The round included investments from individual investors, among them some of the world’s leading endoscopists, experienced medical device entrepreneurs, and other investors with clinical, technical, and business expertise.

“Therapeutic endoscopy holds the potential to treat numerous gastrointestinal conditions in a minimally invasive manner, but achieving this requires the right tools,” said Dr. Mouen Khashab, founder of Sotelix Endoscopy and Director of Therapeutic Endoscopy at Johns Hopkins Medicine. “Sotelix is dedicated to creating these tools to enable incision-free, scar-free treatments, helping patients return to their lives faster.”

Sotelix Endoscopy, Inc., was founded by Dr. Mouen Khashab, a Professor of Medicine at Johns Hopkins University School of Medicine and one of the world’s leading endoscopists. The leadership team includes co-founder Dr. Venkata Akshintala, an associate professor at Johns Hopkins University School of Medicine and pioneer in gastrointestinal medical device development; chairman Mohamad Khachab, a successful entrepreneur and investor; and CEO John Schellhorn.

ABOUT SOTELIX ENDOSCOPY

Sotelix Endoscopy is a privately held medical device startup focused on developing groundbreaking therapeutic endoscopy devices for minimally invasive treatments in the gastrointestinal tract. Sotelix Endoscopy is based in Baltimore, MD. For more information, visit www.sotelix.com.

Contacts

John Schellhorn, Sotelix Endoscopy, john@sotelix.com

(c)2024 Business Wire, Inc., All rights reserved.


Venture Capital
Baltimore, Business Wire, Massachusetts, Sotelix Endoscopy, Venture Capital

Post navigation

NEXT
Fervo Energy Secures Additional $255 Million Funding to Meet Unprecedented Energy Demand
PREVIOUS
Action Behavior Centers to spend $450,000.00 to occupy 6,972 square feet of space in Richmond Texas.
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.